We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.50 | -2.50% | 97.50 | 95.00 | 100.00 | 100.00 | 97.50 | 100.00 | 7,300 | 11:34:19 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Electronic Computers | 1.03M | -2.92M | -0.2188 | -4.46 | 13M |
From Apr 2019 to Apr 2024
TIDMFDBK
RNS Number : 8009D
Feedback PLC
02 May 2017
2 May 2017
Feedback plc
("Feedback", the "Group" or the "Company")
Notice of Resignation of Director
Feedback plc (AIM: FDBK), the medical imaging software company announces that Tom Charlton, non-executive Deputy Chairman of the Company, has given notice to the Board of Feedback that he intends to step down as a director on 30 May 2017 in order to devote more time to his other investment activities. Tom Charlton has indicated that he is prepared to enter into an orderly market agreement in respect of his substantial shareholding after he ceases to be a Director. The directors of the Company intend to appoint a further non-executive director with the appropriate skills to assist the Company in its next stage of development and a further announcement will be made in due course.
Dr. Alastair Riddell, non-executive Chairman, said, "I should like to thank Tom for his invaluable support of the Company following its readmission in 2014 which has enabled it to achieve remarkable progress to date. The recent placing now gives the Company the requisite capital to invest in building its commercial, regulatory and technical support capabilities to match the potential unlocked by the imminent CE mark and major collaborative distribution agreements. I look forward to the board being strengthened with the appointment of a further non-executive director to assist the Company through this significant growth phase."
Tom Charlton said, "Having been the driving force behind Feedback's move into medical imaging, I had always planned to step down as a Director after bringing in Alastair as an experienced Chairman to lead the Company to the next stage in its development. The future success of the Company is my key objective and therefore I am prepared to enter into an orderly market agreement regarding my shareholding to reassure shareholders."
For further information contact:
Feedback plc Tel: 01954 718072 Dr Alastair Riddell Allenby Capital Limited (Nominated Tel: 020 3328 Adviser and Joint Broker) 5656 David Worlidge / Virginia Bull/ James Thomas Northland Capital Partners Ltd (Joint Tel: 020 3861 Broker) 6625 Patrick Claridge / Margarita Mitropoulou Peterhouse Corporate Finance Ltd Tel: 020 7469 (Joint Broker) 0936 Lucy Williams / Duncan Vasey
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAKFLFBDEFXBBV
(END) Dow Jones Newswires
May 02, 2017 02:01 ET (06:01 GMT)
1 Year Feedback Chart |
1 Month Feedback Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
